Continuous induction of chromatid lesions by DNA-intercalating compounds.
D002460:Cell Line; D002842:Chromatids; D002869:Chromosome Aberrations; D002875:Chromosomes; D003609:Dactinomycin / Q000494:pharmacology*; D004317:Doxorubicin / Q000494:pharmacology*; D004996:Ethidium / Q000494:pharmacology*; D007621:Karyotyping; D009153:Mutagens
D009153:Mutagens; D003609:Dactinomycin; D004317:Doxorubicin; D004996:Ethidium